ArticleBMC medicine2026

Targeting CCR7-KMT2D enhances CAR-T cell efficacy by suppressing therapy-induced senescence in B-cell non-Hodgkin lymphoma.

Jinlan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.